benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment
- RxCUI
- 1603377
- RxNorm name
- benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment
- Display name
- Benzocaine/Salicylic acid (Topical)
- Full name
- benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment
- Term type
- SCD
- Status
- Active
- Strength
- 2-55%
- Dose form
- Ointment
- Route
- Topical
- Updated
- 2026-10-15 15:45:04
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042015
- Active start
- 042015
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| benzocaine | 0.02 MG / 1 MG | benzocaine | benzocaine |
| salicylic acid | 0.55 MG / 1 MG | salicylic acid | salicylic acid |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Ointment | 316985 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| benzocaine | 1399 |
| salicylic acid | 9525 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Name | benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Synonym | benzocaine 2 % / salicylic acid 55 % Topical Ointment | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| RxCUI | 1603377 | 1 | CODES |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Salinocaine | SALICYLIC ACID AND BENZOCAINE | Medical Products Laboratories, Inc. | 49d9f83d-3055-f80e-e58a-b6fca192ac8d | 2024-08-07 | 1603377 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 49d9f83d-3055-f80e-e58a-b6fca192ac8d | salicylic acid 550 MG / benzocaine 20 MG per GM Topical Ointment [PSN] · benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment [SCD] · benzocaine 2 % / salicylic acid 55 % Topical Ointment [SY] | 3 | 9 | SALINOCAINE OINTMENT | 20240807 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | benzocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | benzocaine | |
| ATC | S01BC | Antiinflammatory agents, non-steroids | ATC1-4 | salicylic acid | |
| ATC | N01BA | Esters of aminobenzoic acid | ATC1-4 | benzocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | benzocaine | |
| ATC | D01AE | Other antifungals for topical use | ATC1-4 | salicylic acid | |
| FDASPL | N0000185508 | Standardized Chemical Allergen | EPC | has_epc | benzocaine |
| FDASPL | N0000184306 | Cell-mediated Immunity | PE | has_pe | benzocaine |
| FDASPL | N0000175629 | Increased Histamine Release | PE | has_pe | benzocaine |
| MEDRT | D001566 | Benzocaine | CHEM | has_ingredient | benzocaine |
| MEDRT | D020156 | Salicylic Acid | CHEM | has_ingredient | salicylic acid |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | salicylic acid |
| MEDRT | D001424 | Bacterial Infections | DISEASE | ci_with | benzocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | benzocaine |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | salicylic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | salicylic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzocaine |
| MEDRT | D004433 | Earache | DISEASE | may_treat | benzocaine |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | benzocaine |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | benzocaine |
| MEDRT | D006561 | Herpes Simplex | DISEASE | may_treat | benzocaine |
| MEDRT | D017492 | Keratosis, Seborrheic | DISEASE | may_treat | salicylic acid |
| MEDRT | D019226 | Oral Ulcer | DISEASE | may_treat | benzocaine |
| MEDRT | D010032 | Otitis Externa | DISEASE | may_treat | benzocaine |
| MEDRT | D010033 | Otitis Media | DISEASE | may_treat | benzocaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | benzocaine |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | benzocaine |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | salicylic acid |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | salicylic acid |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | benzocaine |
| MEDRT | D014860 | Warts | DISEASE | may_treat | salicylic acid |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | benzocaine |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | salicylic acid |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | benzocaine |
| MEDRT | N0000009974 | Increased Skin Keratinization | PE | has_pe | salicylic acid |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.02 MG/MG / 0.55 MG/MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | VUID | 4034810 |
| NAMES | Prescribable Synonym | salicylic acid 550 MG / benzocaine 20 MG per GM Topical Ointment |